{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T07:30:57Z","timestamp":1792999857325,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21C100002"],"award-info":[{"award-number":["LQ21C100002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1104602"],"award-info":[{"award-number":["2017YFC1104602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2018KY736"],"award-info":[{"award-number":["2018KY736"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2020KY360"],"award-info":[{"award-number":["2020KY360"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.mtbio.2021.100143","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T04:40:30Z","timestamp":1633063230000},"page":"100143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model"],"prefix":"10.1016","volume":"12","author":[{"given":"H.","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mtbio.2021.100143_bib1","first-page":"254","article-title":"Antibody-drug conjugates for cancer therapy, the Lancet","volume":"17","author":"Thomas","year":"2016","journal-title":"Oncology"},{"issue":"9","key":"10.1016\/j.mtbio.2021.100143_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17425247.2020.1698544","article-title":"Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier","volume":"17","author":"Tosi","year":"2020","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.mtbio.2021.100143_bib4","doi-asserted-by":"crossref","first-page":"119358","DOI":"10.1016\/j.biomaterials.2019.119358","article-title":"Polymers for cytosolic protein delivery","volume":"218","author":"Lv","year":"2019","journal-title":"Biomaterials"},{"issue":"sup1","key":"10.1016\/j.mtbio.2021.100143_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/21691401.2018.1430695","article-title":"Passive delivery of protein drugs through transdermal route","volume":"46","author":"Chaulagain","year":"2018","journal-title":"Artif. Cell. Nanomed. Biotechnol."},{"issue":"21","key":"10.1016\/j.mtbio.2021.100143_bib6","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1039\/D0BM01151G","article-title":"Nano and microscale delivery platforms for enhanced oral peptide\/protein bioavailability","volume":"8","author":"Tong","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mtbio.2021.100143_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biomaterials.2017.04.036","article-title":"Protein based therapeutic delivery agents: contemporary developments and challenges","volume":"134","author":"Yin","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijpharm.2017.09.027","article-title":"A\u00a0comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery","volume":"532","author":"R\u00f6hm","year":"2017","journal-title":"Int. J. Pharmaceut."},{"issue":"2","key":"10.1016\/j.mtbio.2021.100143_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11095-019-2689-1","article-title":"In vivo stability of therapeutic proteins","volume":"37","author":"Schuster","year":"2020","journal-title":"Pharmaceut. Res."},{"issue":"2","key":"10.1016\/j.mtbio.2021.100143_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/eop.13.8","article-title":"Corneal neovascularization: a review of the molecular biology and current therapies","volume":"8","author":"Rolfsen","year":"2013","journal-title":"Expet Rev. Ophthalmol."},{"issue":"4","key":"10.1016\/j.mtbio.2021.100143_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/156720112801323125","article-title":"Controlled and continuous release ocular drug delivery systems: pros and cons","volume":"9","author":"Abdelkader","year":"2012","journal-title":"Curr. Drug Deliv."},{"issue":"12","key":"10.1016\/j.mtbio.2021.100143_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121232","article-title":"Biodegradable nanoparticle for cornea drug delivery: focus review","volume":"12","author":"Mobaraki","year":"2020","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.mtbio.2021.100143_bib13","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/mp500332m","article-title":"On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein","volume":"11","author":"Mun","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.mtbio.2021.100143_bib14","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J.\u00a0Pharmaceut. Sci."},{"issue":"4","key":"10.1016\/j.mtbio.2021.100143_bib15","first-page":"444","article-title":"Corneal neovascularization and biological therapy","volume":"8","author":"Voiculescu","year":"2015","journal-title":"J.\u00a0Med. Life"},{"key":"10.1016\/j.mtbio.2021.100143_bib16","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/ICL.0b013e3182a70ef7","article-title":"Review of complications associated with contact lenses from unregulated sources of supply","volume":"40","author":"Young","year":"2014","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.mtbio.2021.100143_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.mtbio.2021.100143_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vision (London, England)"},{"key":"10.1016\/j.mtbio.2021.100143_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000088479","article-title":"VEGF as a therapeutic target in cancer","volume":"69","author":"Ferrara","year":"2005","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.mtbio.2021.100143_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","article-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","volume":"333","author":"Ferrara","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mtbio.2021.100143_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ajo.2020.11.017","article-title":"Biosimilars for retinal diseases: an update","volume":"224","author":"Sharma","year":"2021","journal-title":"Am. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.mtbio.2021.100143_bib23","article-title":"Chemotherapy and targeted agents in the treatment of elderly patients with metastatic colorectal cancer","volume":"9","author":"Tuca","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.mtbio.2021.100143_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.phrs.2015.11.027","article-title":"Targeting VEGF in eye neovascularization: what's new?: a comprehensive review on current therapies and oligonucleotide-based interventions under development","volume":"103","author":"Amadio","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.mtbio.2021.100143_bib25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2174\/1389450121666200319111710","article-title":"Anti-VEGF treatment in corneal diseases","volume":"21","author":"Giannaccare","year":"2020","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11010009","article-title":"Pharmacokinetic simulations of intravitreal biologicals: aspects of drug delivery to the posterior and anterior segments","volume":"11","author":"Rimpel\u00e4","year":"2018","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.mtbio.2021.100143_bib27","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/anie.201708459","article-title":"Nanobodies: chemical functionalization strategies and intracellular applications","volume":"57","author":"Schumacher","year":"2018","journal-title":"Angew. Chem. (Int. ed. in Engl.)"},{"issue":"32\u201333","key":"10.1016\/j.mtbio.2021.100143_bib28","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/adma.200802106","article-title":"Hydrogels in regenerative medicine","volume":"21","author":"Slaughter","year":"2009","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2021.100143_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fimmu.2020.00266","article-title":"Current progress in particle-based systems for transdermal vaccine delivery","volume":"11","author":"Pielenhofer","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2021.100143_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.colsurfb.2017.12.040","article-title":"Anhydrous reverse micelle lecithin nanoparticles\/PLGA composite microspheres for long-term protein delivery with reduced initial burst","volume":"163","author":"Chen","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.mtbio.2021.100143_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.colsurfb.2017.07.057","article-title":"Combination of dexamethasone and Avastin(\u00ae) by supramolecular hydrogel attenuates the inflammatory corneal neovascularization in rat alkali burn model","volume":"159","author":"Huang","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"11","key":"10.1016\/j.mtbio.2021.100143_bib32","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1167\/iovs.14-15257","article-title":"Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization","volume":"55","author":"Kim","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"42","key":"10.1016\/j.mtbio.2021.100143_bib33","doi-asserted-by":"crossref","first-page":"39209","DOI":"10.1021\/acsami.9b15019","article-title":"A\u00a0facile and universal method to efficiently fabricate diverse protein capsules for multiple potential applications","volume":"11","author":"Shi","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2021.100143_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.actbio.2019.03.058","article-title":"Hexahistidine-metal assemblies: a promising drug delivery system","volume":"90","author":"Huang","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2021.100143_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.actbio.2016.04.014","article-title":"Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-\u03b5-caprolactone (PCL)","volume":"37","author":"Sun","year":"2016","journal-title":"Acta Biomater."},{"issue":"23","key":"10.1016\/j.mtbio.2021.100143_bib36","doi-asserted-by":"crossref","first-page":"14488","DOI":"10.1039\/C4NR04761C","article-title":"Supramolecular nanofibers of triamcinolone acetonide for uveitis therapy","volume":"6","author":"Li","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.mtbio.2021.100143_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2014.02.005","article-title":"Alkali burn versus suture-induced corneal neovascularization in C57BL\/6 mice: an overview of two common animal models of corneal neovascularization","volume":"121","author":"Giacomini","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"11","key":"10.1016\/j.mtbio.2021.100143_bib38","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1096\/fj.201700336R","article-title":"Animal models of ocular angiogenesis: from development to pathologies","volume":"31","author":"Liu","year":"2017","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.mtbio.2021.100143_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2613.2008.00633.x","article-title":"A\u00a0critical analysis of current in vitro and in vivo angiogenesis assays","volume":"90","author":"Staton","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"issue":"7","key":"10.1016\/j.mtbio.2021.100143_bib40","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1021\/acsbiomaterials.0c00218","article-title":"Evaluation of his(6)-metal assemblies as a drug delivery vehicle in the treatment of anterior segment disease using a corneal inflammation model","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.mtbio.2021.100143_bib41","first-page":"5168652","article-title":"The wound healing effect of doxycycline after corneal alkali burn in rats","volume":"2019","author":"Yi","year":"2019","journal-title":"J.\u00a0Ophthalmol."},{"issue":"9","key":"10.1016\/j.mtbio.2021.100143_bib42","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015905","article-title":"A\u00a0novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis","volume":"6","author":"Bhattacharjee","year":"2011","journal-title":"PloS One"},{"issue":"206","key":"10.1016\/j.mtbio.2021.100143_bib44","doi-asserted-by":"crossref","first-page":"eg2","DOI":"10.1126\/scisignal.2002806","article-title":"Focus issue: wnt and \u03b2-catenin signaling in development and disease","volume":"5","author":"Gough","year":"2012","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.mtbio.2021.100143_bib45","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.xphs.2018.11.038","article-title":"Alginate-based delivery systems for bevacizumab local therapy: in vitro structural features and release properties","volume":"108","author":"Ferreira","year":"2019","journal-title":"J.\u00a0Pharmaceut. Sci."},{"key":"10.1016\/j.mtbio.2021.100143_bib46","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2147\/IJN.S195504","article-title":"Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy","volume":"14","author":"Sun","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"31","key":"10.1016\/j.mtbio.2021.100143_bib47","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1021\/jacs.8b04457","article-title":"Biomineralized metal-organic framework nanoparticles enable intracellular delivery and endo-lysosomal release of native active proteins","volume":"140","author":"Chen","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2021.100143_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2018.02.003","article-title":"Human serum albumin nanoparticles for ocular delivery of bevacizumab","volume":"541","author":"Luis de Red\u00edn","year":"2018","journal-title":"Int. J. Pharmaceut."},{"issue":"8","key":"10.1016\/j.mtbio.2021.100143_bib49","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.mtbio.2021.100143_bib50","first-page":"4147","article-title":"Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups","volume":"7","author":"Ekkapongpisit","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.mtbio.2021.100143_bib51","first-page":"3653","article-title":"Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor","volume":"186","author":"Suryawanshi","year":"2011","journal-title":"J.\u00a0Immunol. (Baltimore, Md.: 1950)"},{"issue":"15","key":"10.1016\/j.mtbio.2021.100143_bib52","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1039\/c2nr30924f","article-title":"Diclofenac\/biodegradable polymer micelles for ocular applications","volume":"4","author":"Li","year":"2012","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.mtbio.2021.100143_bib53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","article-title":"Corneal nerves in health and disease","volume":"59","author":"Shaheen","year":"2014","journal-title":"Surv. Ophthalmol."},{"issue":"4","key":"10.1016\/j.mtbio.2021.100143_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3844\/ajbbsp.2015.221.227","article-title":"Review of the progress in corneal neovascularization animal models","volume":"11","author":"Tian","year":"2015","journal-title":"Am. J. Biochem. Biotechnol."},{"issue":"7","key":"10.1016\/j.mtbio.2021.100143_bib55","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-015-2954-x","article-title":"Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model","volume":"253","author":"Kuerten","year":"2015","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.22336\/rjo.2019.4","article-title":"Corneal neovascularization: updates on pathophysiology, investigations & management","volume":"63","author":"Sharif","year":"2019","journal-title":"Rom. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.mtbio.2021.100143_bib57","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI126655","article-title":"Roles of HIFs and VEGF in angiogenesis in the retina and brain","volume":"129","author":"Rattner","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mtbio.2021.100143_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mtbio.2021.100143_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/178132","article-title":"Treatment of corneal neovascularization using anti-VEGF bevacizumab","volume":"2014","author":"Krizova","year":"2014","journal-title":"J.\u00a0Ophthalmol."},{"issue":"5","key":"10.1016\/j.mtbio.2021.100143_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/nu11051184","article-title":"Cucurbita argyrosperma seed extracts attenuate angiogenesis in a corneal chemical burn model","volume":"11","author":"Estrella-Mendoza","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.colsurfb.2007.06.013","article-title":"The expression patterns of vascular endothelial growth factor and thrombospondin 2 after corneal alkali burn","volume":"60","author":"Yan","year":"2007","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.mtbio.2021.100143_bib62","article-title":"Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization","volume":"9","author":"Chen","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12011-017-1119-7","article-title":"Zinc metabolism and metallothioneins","volume":"183","author":"Baltaci","year":"2018","journal-title":"Biol. Trace Elem. Res."},{"issue":"1","key":"10.1016\/j.mtbio.2021.100143_bib64","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1166\/jnn.2014.9078","article-title":"Physiologically important metal nanoparticles and their toxicity","volume":"14","author":"Sengupta","year":"2014","journal-title":"J.\u00a0Nanosci. Nanotechnol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259000642100051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259000642100051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:21:00Z","timestamp":1762906860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259000642100051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":64,"alternative-id":["S259000642100051X"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2021.100143","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2021.100143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100143"}}